Yanling Feng

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 227 citations

Medicine, Gynecology, Oncology +16

Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer

He Huang, Yanling Feng, Ting Wan et al. · JAMA Oncology · 2021 · 128 citations · Full text

Medicine, Gynecology, Oncology +16

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

Xiaohua Wu, Lingying Wu, Beihua Kong et al. · International Journal of Gynecological Cancer · 2017 · 119 citations

Medicine, Gynecology, Oncology +17

SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation

Wenyu Zhang, Yanling Feng, Qiqiang Guo et al. · Cell Death and Differentiation · 2019 · 86 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study

Guangyao Cai, Fangjun Huang, Yue Gao et al. · The Lancet Digital Health · 2024 · 79 citations · Full text

Computing, Gynecology, Oncology +17